Regional Office: China
Specialty: Healthcare Strategy & Commercialisation
Language: English, Mandarin
Dr. Yu (Robin) Zhang the Associate Director of Strategic Planning & Business
Development at Pfizer Consumer Healthcare (PCH). In this position, he is responsible for
developing growth strategy, identifying business opportunities to maintain PCH’s leading
position in the China market.
Before joining Pfizer, Dr. Zhang served several roles at Bayer Healthcare including: Head
of Business Development (China), Head of Strategic Marketing (China) and acting Head
of Bayer China (Glucose Meter Business Unit). Dr. Zhang gained his professional
experience in Pfizer Rx, IMS Consulting, the Alfred Mann Foundation (US) and UBS
Investment Bank (US).
Dr. Zhang holds a Medical Degree from Peking University. After an Orthopedic Residency
at Peking University First Hospital, he studied at the University of Rochester and became
the first PhD/MBA joint degree student in US history. He graduated from Rochester with
a PhD in Pathology and an MBA in Finance and Healthcare management.
Dr. Zhang is an expert developing corporate and product strategy based on clinical
impact, regulatory, reimbursement/pricing parameters, the competitive environment and
HEOR results. Simone Song, the Managing Director of Goldman Sachs (Asia) Healthcare
IBD, said: “Robin is the best strategist in China pharmaceutical industry.”
Dr. Zhang won the highly prestigious New Investigator Recognition Award (2007) from
the Orthopedic Research Society and is a frequent speaker in key industry conferences.